Received May 12, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | YE232 | IM / LA |
Patient received a second dose of Arexvy after receiving first dose in August 2023. No adverse reactions reported as of yet.
N/A
Hypertension, Hypercholesterolemia, Diabetes
Diltiazem, Pravastatin, Metformin
NKDA